Literature DB >> 21692802

Repeated exposure to cocaine alters medial prefrontal cortex dopamine D₂-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system.

Kun Liu1, Jeffery D Steketee.   

Abstract

Repeated exposure to cocaine progressively increases drug-induced locomotor activity, which is termed behavioral sensitization. Previous studies have demonstrated that sensitization to cocaine is associated with a decrease in dopamine D₂ receptor function in the medial prefrontal cortex. The present report tested the hypothesis that reduced medial prefrontal cortex D₂ receptor function as a result of repeated cocaine exposure results in augmented excitatory transmission to the nucleus accumbens and ventral tegmental area, possibly as a partial result of enhanced inhibition of local dopamine release. Dual probe microdialysis experiments were conducted in male Sprague-Dawley rats 1, 7 or 30 days following the last of four daily injections of saline (1.0 mL/kg) or cocaine (15 mg/kg). Infusion of quinpirole (0.01, 1.0 and 100 μM), a D₂-like receptor agonist, into the medial prefrontal cortex produced a dose-dependent decrease in cortical, nucleus accumbens and ventral tegmental area extracellular glutamate levels in control but not sensitized animals. Quinpirole also reduced basal dopamine levels in the medial prefrontal cortex in sensitized animals following 1 day of withdrawal from cocaine. Following 30 days of withdrawal, quinpirole also reduced dopamine levels in sensitized animals relative to saline controls, but not relative to baseline levels. These findings indicate that the expression of sensitization to cocaine is associated with altered modulation of mesocorticolimbic glutamatergic transmission at the level of the medial prefrontal cortex.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692802     DOI: 10.1111/j.1471-4159.2011.07362.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Examination of a role for metabotropic glutamate receptor 5 in the medial prefrontal cortex in cocaine sensitization in rats.

Authors:  Kristin M Timmer; Jeffery D Steketee
Journal:  Psychopharmacology (Berl)       Date:  2011-11-16       Impact factor: 4.530

2.  Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.

Authors:  Xinjiang Kang; Huadong Xu; Sasa Teng; Xiaoyu Zhang; Zijun Deng; Li Zhou; Panli Zuo; Bing Liu; Bin Liu; Qihui Wu; Li Wang; Meiqin Hu; Haiqiang Dou; Wei Liu; Feipeng Zhu; Qing Li; Shu Guo; Jingli Gu; Qian Lei; Jing Lü; Yu Mu; Mu Jin; Shirong Wang; Wei Jiang; Kun Liu; Changhe Wang; Wenlin Li; Kang Zhang; Zhuan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

3.  Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex.

Authors:  V Echeverry-Alzate; E Giné; K M Bühler; J Calleja-Conde; P Olmos; M A Gorriti; R Nadal; F Rodríguez de Fonseca; J A López-Moreno
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

4.  Serotonin (2C) receptor regulation of cocaine-induced conditioned place preference and locomotor sensitization.

Authors:  Caryne P Craige; Ellen M Unterwald
Journal:  Behav Brain Res       Date:  2012-10-26       Impact factor: 3.332

Review 5.  Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system.

Authors:  Matthew C Hearing; Anastasia N Zink; Kevin Wickman
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

6.  Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation.

Authors:  Kevin D Lominac; Courtney L McKenna; Lisa M Schwartz; Paige N Ruiz; Melissa G Wroten; Bailey W Miller; John J Holloway; Katherine O Travis; Ganesh Rajasekar; Dan Maliniak; Andrew B Thompson; Lawrence E Urman; Tamara J Phillips; Karen K Szumlinski
Journal:  Front Syst Neurosci       Date:  2014-05-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.